查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1210911

雙胍全球市場規模研究和預測：按類型（二甲雙胍 IR、二甲雙胍 ER、其他雙胍）、按劑型（片劑、溶液）、區域分析，2022-2029 年

Global Biguanides Market Size study & Forecast, by Type (Metformin IR, Metformin ER, Other Biguanide), By Dosage Form (Tablet and Solution) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

雙胍類藥物用於治療 2 型糖尿病。

它的作用是抑制消化過程中產生的葡萄糖。 包括 Glucophage（二甲雙胍）、Glucophage XR（二甲雙胍緩釋片）、Fortamet、Grumezza 和 Riomet。 由於糖尿病患者增加和醫療保健支出增加等因素，雙胍類藥物的市場正在擴大。

根據國際糖尿病聯合會 (IDF) 2021 年版的數據，患有糖尿病的成人人數約為 5.37 億，預計到 2030 年將增至 6.43 億。 肥胖、不健康的飲食和缺乏運動導致新診斷的 1 型和 2 型糖尿病的增加。 與此同時，技術創新和進步，以及抗生素使用的增加，正在為市場創造有利可圖的機會。 然而，替代品的威脅阻礙了整個 2022-2029 年預測期內的市場增長。

全球雙胍市場研究考慮的主要區域包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於糖尿病人口增加、抗藥使用增加以及醫療保健成本上升，亞太地區在收入方面佔據市場主導地位。 另一方面，由於市場進入者數量增加和研發活動增加等因素，預計亞太地區在預測期內將顯著增長。

這項研究的目的是揭示近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年按全球市場和細分劃分的市場估計和預測
    • 雙胍類市場：按地區劃分，2019-2029 年
    • 雙胍類市場：按類型分類，2019-2029 年
    • 雙胍市場：按配方分類，2019-2029 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章雙胍全球市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 調查年份
  • 貨幣兌換率

第3章全球雙胍類藥物市場動態

  • 雙胍類藥物市場影響分析（2019-2029）
    • 市場驅動力
      • 糖尿病患者增加
      • 醫療支出增加
    • 市場挑戰
      • 替代品的威脅
    • 市場機會
      • 創新與進步
      • 增加抗生素的使用

第四章全球雙胍市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 投資招聘模式
  • 分析師的結論和建議
  • 頂級投資機會
  • 關鍵成功策略

第 5 章風險評估 COVID-19 影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球雙胍市場，按類型

  • 市場概況
  • 按類型分列的雙胍類全球市場表現 - 潛力分析
  • 2019-2029 年全球雙胍市場、按類型估算和預測
  • 雙胍類藥物市場、細分市場分析
    • 二甲雙胍紅外
    • 二甲雙胍緩釋片
    • 其他雙胍

第 7 章：全球雙胍市場：按配方分類

  • 市場概況
  • 全球雙胍市場：按劑型進行性能潛力分析
  • 雙胍全球市場、按配方估算和預測 (2019-2029)
  • 雙胍市場、細分市場分析
    • 藥片
    • 解決方案

第 8 章全球雙胍市場：區域分析

  • 雙胍全球市場、區域市場概況
  • 北美
    • 美國
      • 按類型估算和預測，2019-2029 年
      • 按劑型估算和預測，2019-2029 年
    • 加拿大
  • 歐洲雙胍市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太雙胍市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲雙胍類藥物市場概況
    • 巴西
    • 墨西哥
  • 世界其他地區

第 9 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • Teva
      • 主要信息
      • 概覽
      • 財務信息（取決於數據可用性）
      • 產品概述
      • 近期趨勢
    • Merck
    • Takeda
    • GlaxoSmithKline
    • Sanofi
    • Boehringer Ingelheim Pharmaceuticals
    • Glenmark
    • AstraZeneca
    • Bristol-Myers Squibb
    • Aarti Drugs Ltd.

第 10 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查屬性
  • 調查先決條件

Global Biguanides Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Biguanides are medications used for the treatment of type 2 diabetes. It works by reducing the glucose production that occurs during digestion. It includes Glucophage (metformin) and Glucophage XR (metformin extended release), Fortamet, Glumetza, and Riomet. The Biguanides market is expanding because of factors such as the rising cases of diabetic patients and growing healthcare expenditure

According to International Diabetes Federation (IDF) 2021, the adult diabetes population will be around 537 million in 2021, rising to 643 million by 2030. Obesity, an unhealthy diet, and physical inactivity are all contributing to an increase in newly diagnosed Type 1 and Type 2 diabetes cases. Whereas rising technological innovations and advancement & growing usage of anti-biotic drugs create lucrative opportunities for the market. However, the threat of substitutes hampers the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Biguanides Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. The Asia Pacific dominated the market in terms of revenue, owing to the increasing cases of diabetic patients, growing adoption of anti-drugs, and rising healthcare expenditure. Whereas the Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the growing penetration of market players and rising R&D activities.

Major market players included in this report are:

Teva

Merck

Takeda

GlaxoSmithKline

Sanofi

Boehringer Ingelheim Pharmaceuticals

Glenmark

AstraZeneca

Bristol-Myers Squibb

Aarti Drugs Ltd.

Recent Developments in the Market:

  • In July 2021, In India, the Drug Pricing Authority (NPPA) set retail prices for 84 drug formulations, including those used to treat diabetes, headaches, and high blood pressure. A single tablet of (SR) Metformin Hydrochloride will cost Rs 10.47, excluding GST, according to the order.
  • In July 2022, Glenmark Pharmaceuticals Limited has made sitagliptin and its Fixed Dose Combinations (FDCs) with metformin and other anti-diabetic drugs available at a low cost to adults with Type 2 diabetes. Each of these brands will have two variants: SITAZIT M (50 mg) + metformin (500 mg/1000 mg); SITAZIT M ER (100 mg) + metformin SR (500 mg/1000 mg). These medications have a low risk of hypoglycemia, protect beta cells, provide cardio-renal benefits, and are safe for patients with kidney or liver disease as well as seniors.

Global Biguanides Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Type, Dosage Form, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Metformin IR,

Metformin ER,

Other Biguanide

By Dosage Form:

Tablets

Solution

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Biguanides Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Biguanides Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Biguanides Market, by Dosage Form, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Biguanides Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Biguanides Market Dynamics

  • 3.1. Biguanides Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising cases of diabetic patients
      • 3.1.1.2. Growing healthcare expenditure
    • 3.1.2. Market Challenges
      • 3.1.2.1. Threat of substitute
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological innovations and advancements
      • 3.1.3.2. Growing usage of anti-biotic drugs

Chapter 4. Global Biguanides Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Biguanides Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Biguanides Market by Type, Performance - Potential Analysis
  • 6.3. Global Biguanides Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Biguanides Market, Sub Segment Analysis
    • 6.4.1. Metformin IR,
    • 6.4.2. Metformin ER,
    • 6.4.3. Other Biguanide

Chapter 7. Global Biguanides Market, by Dosage Form

  • 7.1. Market Snapshot
  • 7.2. Global Biguanides Market by Dosage Form, Performance - Potential Analysis
  • 7.3. Global Biguanides Market Estimates & Forecasts by Dosage Form 2019-2029 (USD Billion)
  • 7.4. Biguanides Market, Sub Segment Analysis
    • 7.4.1. Tablets
    • 7.4.2. Solution

Chapter 8. Global Biguanides Market, Regional Analysis

  • 8.1. Biguanides Market, Regional Market Snapshot
  • 8.2. North America Biguanides Market
    • 8.2.1. U.S. Biguanides Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Dosage Form breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Biguanides Market
  • 8.3. Europe Biguanides Market Snapshot
    • 8.3.1. U.K. Biguanides Market
    • 8.3.2. Germany Biguanides Market
    • 8.3.3. France Biguanides Market
    • 8.3.4. Spain Biguanides Market
    • 8.3.5. Italy Biguanides Market
    • 8.3.6. Rest of Europe Biguanides Market
  • 8.4. Asia-Pacific Biguanides Market Snapshot
    • 8.4.1. China Biguanides Market
    • 8.4.2. India Biguanides Market
    • 8.4.3. Japan Biguanides Market
    • 8.4.4. Australia Biguanides Market
    • 8.4.5. South Korea Biguanides Market
    • 8.4.6. Rest of Asia Pacific Biguanides Market
  • 8.5. Latin America Biguanides Market Snapshot
    • 8.5.1. Brazil Biguanides Market
    • 8.5.2. Mexico Biguanides Market
  • 8.6. Rest of The World Biguanides Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Teva
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Merck
    • 9.2.3. Takeda
    • 9.2.4. GlaxoSmithKline
    • 9.2.5. Sanofi
    • 9.2.6. Boehringer Ingelheim Pharmaceuticals
    • 9.2.7. Glenmark
    • 9.2.8. AstraZeneca
    • 9.2.9. Bristol-Myers Squibb
    • 9.2.10. Aarti Drugs Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Biguanides Market, report scope
  • TABLE 2. Global Biguanides Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Biguanides Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Biguanides Market estimates & forecasts by Dosage Form 2019-2029 (USD Billion)
  • TABLE 5. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Biguanides Market
  • TABLE 70. List of primary sources, used in the study of global Biguanides Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Biguanides Market, research methodology
  • FIG 2. Global Biguanides Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Biguanides Market, key trends 2021
  • FIG 5. Global Biguanides Market, growth prospects 2022-2029
  • FIG 6. Global Biguanides Market, porters 5 force model
  • FIG 7. Global Biguanides Market, pest analysis
  • FIG 8. Global Biguanides Market, value chain analysis
  • FIG 9. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Biguanides Market, regional snapshot 2019 & 2029
  • FIG 15. North America Biguanides Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Biguanides Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Biguanides Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Biguanides Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Biguanides Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable